Cochlear Implant PDA Based Research Platform

NCT ID: NCT01620385

Last Updated: 2012-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of the research is to study how individuals who wear cochlear implants process sounds in noisy environments and also whether newly designed programs can help improve the communicative ability of cochlear implant patients in noisy situations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cochlear implants have been successful in restoring partial hearing to profoundly deaf people. Despite their success, most implant patients are not able to communicate in noisy environments (e.g., in a restaurant). Communicating in noise still remains one of the biggest challenges in cochlear implants. Little is known about the factors that contribute to the poor performance of CI users in noise. In this project, we propose a series of experiments aimed at isolating these factors. We propose new programs that can be tailored for noisy situations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hearing Impaired

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ciPDA

Group Type EXPERIMENTAL

ciPDA

Intervention Type DEVICE

The ciPDA Research Platform device was designed as a research tool for cochlear implant research.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ciPDA

The ciPDA Research Platform device was designed as a research tool for cochlear implant research.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Single arm study.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Post-lingually deafened adults:

* 18 years of age or older
* Unilateral or bilateral Nucleus implant users (this includes all three generations of the Nucleus system, i.e., CI22, CI24 and CI24R).
* With or without residual hearing in the contralateral ear. Subjects may use amplification (hearing aid) in the opposite or same ear as the implant.
* A minimum test score of 30% in tape-recorded open-set sentence recognition scores (e.g., spondee identification).
* Minimum of 6 months experience with their implant device. This is done to ensure that all patients are familiar with the hearing sensations perceived by a cochlear implant.
* Minimum number of active electrodes: 10
* Minimum number of subjects for each test site: 5
2. Prelingually and perilingually deafened adults:

* 18 years of age or older
* Unilateral or bilateral Nucleus implant users.
* With or without residual hearing in the contralateral ear. Subjects may use amplification (hearing aid) in the opposite or same ear as the implant.
* A minimum test score of 10% in tape-recorded open-set sentence recognition scores (e.g., spondee identification).
* Minimum of 6 months experience with their implant device. This is done to ensure that all patients are familiar with the hearing sensations perceived by a cochlear implant.
* Minimum number of active electrodes: 10
* Minimum number of subjects for each test site: 5

Exclusion Criteria

* Non-English speaking
* Hearing loss of neural or central origin
* Absence of cochlear or VIII nerve development
* The presence of systemic condition which would preclude use of a cochlear implant
* Active middle ear infection/tympanic membrane perforation
* Significantly abnormal cognitive function, as determined by case history information and/or clinical observations
* Significant psychiatric disorder, as determined by case history information and/or clinical observations
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Philip Loizou

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philip Loizou

PI

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philip Loizou, PhD

Role: PRINCIPAL_INVESTIGATOR

The University of Texas at Dallas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas - Dallas

Richardson, Texas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philip Loizou, PhD

Role: CONTACT

972-883-4617

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ciPDA0001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.